iChoose Decision Kidney Aid for End-Stage Renal Disease Patients

Conditions:Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Age Range:18 - Any
Start Date:September 2014
End Date:September 2017

Use our guide to learn which trials are right for you!

iChoose Kidney Decision Aid for Treatment Options Among End-Stage Renal Disease (ESRD) Patients

The investigators developed iChoose Kidney -- a shared decision-making support tool
accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers
with a simple, standardized, easily accessible, statistically robust tool for use in the
clinic to guide patient education and healthcare decision-making about treatment options of
dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with
estimates of their individualized 1 and 3-year risks of mortality on dialysis vs.
transplantation, based on previous national data. The tool has the potential to improve
communication and decision-making between patients and their healthcare providers and improve
access to kidney transplantation among patients with ESRD.

This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers
with diverse patient populations. One group of patients will receive standard education alone
during their scheduled transplant evaluation. The second group will receive the standard
education as well have the provider use the iChoose Kidney aid with them. The project
timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and
outcome evaluation.

This study will assess how well the iChoose decision aid works in improving patient
knowledge, preferences for treatment, and patient access to transplant. The study will also
assess whether providers find the tool useful for providing ways to share information with
patients about ways to treat their kidney disease.

Inclusion Criteria:

- Diagnosis of end-stage renal disease (ESRD) and on dialysis for < 1 year

- English-speaking

- Subjects coming in for transplant medical evaluation

- Age > 18 years

Exclusion Criteria:

- Severe cognitive or visual impairment
We found this trial at
630 W 168th St
New York, New York
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
New York, NY
Click here to add this to my saved trials
Atlanta, Georgia 30322
Atlanta, GA
Click here to add this to my saved trials
Chicago, IL
Click here to add this to my saved trials